Buy 2CBFly-NBOMe Cas 1335331-42-4

Buy 2CBFly-NBOMe Cas 1335331-42-4

2CBFly-NBOMe, also known as NBOMe-2C-B-FLY or as Cimbi-31, is a serotonin receptor modulator of the phenethylamine, DOx, and FLY families. It was indirectly derived from the phenethylamine hallucinogen 2C-B is and related to benzodifurans like 2C-B-FLY and N-benzylphenethylamines like 25B-NBOMe.

2CBFly-NBOMe acts as a potent partial agonist for the 5-HT_2A serotonin receptor subtype.^[1][2][3]

2CBFly-NBOMe was discovered in 2002,^[4] and further researched by Ralf Heim at the Free University of Berlin,^[5] and subsequently investigated in more detail by a team at Purdue University led by David E. Nichols.^[6]

2CBFly-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.^[7]

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.^[8]

2CBFly-NBOMe is not an explicitly controlled substance in the United States.^[9] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

2CBFly-NBOMe is a controlled substance in Vermont as of January 2016.^[10]